Identification of adjuvants that enhance the therapeutic antibody response to host IgE

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2873-2880

  Johansson, Jeannette ^a   Ledin, Anna ^a   Vernersson, Molly ^a   Lövgren Bengtsson, Karin ^b   Hellman, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Isconova AB   (Sweden)

Author keywords

Allergy; bovine serum albumin; BSA; FCA; FIA; Freund's complete adjuvant; Freund's incomplete adjuvant; i.p.; IgE; immunoglobulin E; intraperitoneal; OVA; ovalbumin; Therapeutic vaccines

Indexed keywords

ADJUVANT; ALLHYDROGEL; ALUMINUM HYDROXIDE; ANTIGEN; FORMYLMETHIONINE; FREUND ADJUVANT; IMMUNOGLOBULIN E; ISCOM; MINERAL OIL; MONTANIDE ISA 51; MONTANIDE ISA 720; MURAMYL DIPEPTIDE; ORO VACCINE; PHOSPHORYL LIPID A; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG IDENTIFICATION; FEMALE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN E; LIPID A; MINERAL OIL; OPOSSUMS; PLANT OILS; RATS; RATS, WISTAR;

EID: 3142536721     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.12.029     Document Type: Article

References (21)

1. Noon L., Cantab B.C., Eng F.R.C.S. Prophylactic inoculation against hay fever. Lancet. i:1911;1572-1573
2. Freeman J. Vaccination against hay fever: report of results during the first three years. Lancet. i:1914;1178-1180
3. Hellman L. Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine. Eur. J. Immunol. 24(2):1994;415-420
4. Hellman L., Carlsson M. Allergy vaccines: a review of developments. Clin. Immunother. 6(2):1996;130-142
5. Hellman L. Vaccines against allergies. In: Perlmann P, Wigzell H, editors. Handbook of experimental pharmacology (vaccines), vol. 133. Berlin: Springer-Verlag; 1999. p. 499-526.
6. Vernersson M., Ledin A., Johansson J., Hellman L. Generation of therapeutic antibody responses against IgE through vaccination. FASEB J. 16:2002;875-877
7. Lövgren-Bengtsson K. Preparation and use of adjuvants. In: Methods in microbiology, vol. 25. New York: Academic Press; 1998. p. 471.
8. Aucouturier J., Dupuis L., Deville S., Ascarateil S., Ganne V. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev. Vaccines. 1(1):2002;111-118
9. Lindblad EB. Aluminium adjuvants. In: Stewart-Tull DES, editor. The theory and practical application of adjuvants. Chichester: Wiley; 1995. p. 21-35.
10. Cox J.C., Coulter A.R. Adjuvants: a classification and review of their modes of action. Vaccine. 15(3):1997;248-256
11. Singh M., O'Hagan D. Advances in vaccine adjuvants. Nat. Biotechnol. 17(11):1999;1075-1081
12. Barr I.G., Sjolander A., Cox J.C. ISCOMs and other saponin based adjuvants. Adv. Drug Deliv. Rev. 32(3):1998;247-271
13. Mumford J.A., Jessett D., Dunleavy U., Wood J., Hannant D., Sundquist B., et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine. 12(9):1994;857-863
14. Andersson C., Wikman M., Lövgren-Bengtsson K., Lundén A., Ståhl S. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation. J. Immunol. Methods. 255(1-2):2001;135-148
15. Takada H, Kotani S. Muramyl dipeptide and derivatives. In: Stewart DES, editor. The theory and practical application of adjuvants. Chichester: Wiley; 1995. p. 171-202.
16. Ribi E.E., Cantrell J.L., Von Eschen K.B., Schwartzman S.M. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res. 39(11):1979;4756-4759
17. Baldridge J.R., Crane R.T. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. Methods. 19(1):1999;103-107
18. Hellman L., Pettersson U., Engstrom A., Karlsson T., Bennich H. Structure and evolution of the heavy chain from rat immunoglobulin E. Nucleic Acids Res. 10(19):1982;6041-6049
19. Aveskogh M., Hellman L. Evidence for an early appearance of modern post-switch isotypes in mammalian evolution cloning of IgE. Eur. J. Immunol. 28(9):1998;2738-2750
20. Talwar G.P. Vaccines for control of fertility and hormone-dependent cancers. Immunol. Cell Biol. 75(2):1997;184-189
21. Talwar G.P., Singh O.M., Gupta S.K., Hasnain S.E., Pal R., Majumbar S.S., et al. The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine. Am. J. Reprod. Immunol. 37(2):1997;153-160